Sign in

Guillaume Grenet

@guillaume-grenet.bsky.social
159 followers 278 following 3 posts

#pharmaco #diabeto #meta #endocrino #toxico

PostsRepliesMedia
Guillaume Grenet @guillaume-grenet.bsky.social · 20/06/2025
follow-up www.bmj.com/content/389/... Investigation "Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug", BMJ 2025
bmj.com
000
Guillaume Grenet @guillaume-grenet.bsky.social · 07/05/2025
"Drug Versioning and Legal Accountability for Preventable Product Harms", Viewpoint in JAMA 2025 jamanetwork.com/journals/jam...
jamanetwork.com
Drug Versioning and Legal Accountability for Preventable Product Harms
This Viewpoint discusses drug versioning and legal accountability for preventable product harms.
010
Reposted by Guillaume Grenet
Société Française de Pharmacologie et de Thérapeutique @sfpt-fr.org · 05/05/2025
La FAQ concernant la Formation Spécialisée Transversale (FST) Pharmacologie Médicale et Thérapeutique (PMT) vient d'être mise à jour! Retrouvez là ici (site du CNPM) pharmacomedicale.org/les-formatio...
pharmacomedicale.org
La FST Pharmacologie Médicale et Thérapeutique (PMT)
Permet aux étudiants, professionnels de santé, et au grand public, d'accéder librement à une information sur le médicament validée par les pharmacologues médica
074
Reposted by Guillaume Grenet
The BMJ @bmj.com · 04/02/2025
The US was considered a world leader in public health and research. With one repressive stroke that reputation risks being broken, argue @jocalynclark.bsky.social and @kamranabbasi.bsky.social www.bmj.com/content/388/...
69960
Reposted by Guillaume Grenet
Therapeutics Initiative (TI) @drug-evidence.bsky.social · 22/01/2025
@ubcpublichealth.bsky.social is looking for a post-doc to join a national research program on community antibiotic stewardship! Don't miss out! ubc.wd10.myworkdayjobs.com/ubcfacultyjobs
ubc.wd10.myworkdayjobs.com
UBC - One of the World's Leading Universities As one of the world's leading universities, the University of British Columbia creates an exceptional learning environment that fosters global citizenship, advances a civil and sustainable society, and supports outstanding research to serve the people of British Columbia, Canada and the world. UBC hires on the basis of merit and is committed to employment equity. All qualified persons are encouraged to apply. Equity and diversity are essential to academic excellence. An open and diverse community fosters the inclusion of voices that have been underrepresented or discouraged. We encourage applications from members of groups that have been marginalized on any grounds enumerated under the B.C. Human Rights Code, including sex, sexual orientation, gender identity or expression, racialization, disability, political belief, religion, marital or family status, age, and/or status as a First Nation, Metis, Inuit, and/or Indigenous person. All qualified candidates are encouraged to apply; however Canadians and permanent residents will be given priority. If you have any accommodation or accessibility needs during the job application process, please contact the Centre for Workplace Accessibility at workplace.accessibility@ubc.ca.
012
Reposted by Guillaume Grenet
Société Française de Pharmacologie et de Thérapeutique @sfpt-fr.org · 19/01/2025
Nouveau #pharmacofact sur notre site : Il porte sur le mésusage et la désinformation autour du bleu de méthylène, présenté récemment, sans base factuelle, comme remède miracle du cancer par plusieurs publications et médias destinés au grand public. sfpt-fr.org/pharmacofact... @lexpress.bsky.social
sfpt-fr.org
#F023 Mésusage et désinformation autour du bleu de méthylène
Société Française de Pharmacologie et de Thérapeutique
02211
Reposted by Guillaume Grenet
Stéphanie Benz @stephaniebenz.bsky.social · 20/01/2025
Du bleu de méthylène contre le cancer ? Face aux étranges recommandations du Dr Laurent Schwartz, ⁦ @drbarriere.bsky.social et ⁦@mathieumolimard.bsky.social de la @sfpt-fr.org lancent l’alerte. A lire sur @lexpress.bsky.social ✒️⁦ @antoinebeau.bsky.social 👇 www.lexpress.fr/sciences-san...
lexpress.fr
Du bleu de méthylène contre le cancer ? Les étranges recommandations du Dr Schwartz
Livres, entretiens, conférences… Le cancérologue Laurent Schwartz assure, sans le démontrer, qu’il a découvert un remède universel aux tumeurs. Selon nos informations, l’Ordre des médecins a été saisi...
02210
Reposted by Guillaume Grenet
Fundamental and Clinical Pharmacology Journal (SFPT) @fcp-sfpt.bsky.social · 09/01/2025
SFPT annual meeting 2025 - 24-26th of June Abstract submission deadline extended to 12th of January! www.congres-sfpt.fr/abstract.asp... #SFPT #pharmacology #medication #cardiovascular #oncology #pharmacoepidemiology #pharmacovigilance #pharmacogenetic
congres-sfpt.fr
Congrès SFPT 2025
013
Reposted by Guillaume Grenet
Therapeutics Initiative (TI) @drug-evidence.bsky.social · 08/01/2025
🆕 #BestEvidence webinar recording 😍 Safe & sound: Polypharmacy & rational primary care ti.ubc.ca/drugevidence24 Dr. Dee Mangin describes vital aspects of primary care in maximizing therapeutic benefit + provides examples/areas of challenge for rational treatment #DrugEvidence24 #medsky #pharmsky
087
Reposted by Guillaume Grenet
JAMA @jama.com · 08/01/2025
While glucagon prescriptions for severe hypoglycemia in Medicaid decreased between 2012 and 2018, they increased from 2019 to 2023 with the introduction of newer, easier-to-use glucagon products. ja.ma/4jaCKfm
Figure 1. Glucagon Prescriptions in Medicaid by Glucagon Product from 2012 to 2013
0112
Reposted by Guillaume Grenet
JAMA @jama.com · 06/01/2025
Treatment of gestational diabetes with metformin and additional glyburide, if needed, was not noninferior to insulin in preventing infants from being born large for gestational age. #MedSky ja.ma/40mVHEk
1143
Reposted by Guillaume Grenet
NEJM.org @nejm.org · 06/01/2025
The OCEANIC-AF randomized trial of the factor XIa inhibitor asundexian was stopped early owing to a higher incidence of stroke or systemic embolism than with apixaban therapy among patients with atrial fibrillation. Full trial results: nej.md/473TRdc #MedSky
The New England Journal of Medicine    
Asundexian vs. Apixaban in Atrial Fibrillation  
A PLAIN LANGUAGE SUMMARY    

Visual representation of atrial fibrillation.    

Read the full Plain Language Summary at NEJM.org.
0118
Reposted by Guillaume Grenet
Clara Locher @claralocher.bsky.social · 17/12/2024
Premier Winter Camp de la @sfpt-fr.org « décider à partir des études clinique » : les inscriptions ouvertes ! sfpt-fr.org?view=article...
065
Reposted by Guillaume Grenet
Société Française de Pharmacologie et de Thérapeutique @sfpt-fr.org · 17/12/2024
Communiqué de presse de la SFPT: Rétractation de l’étude Gautret et coll. (Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial) : une page sombre de la recherche sur la COVID-19 enfin tournée . A lire 👉 sfpt-fr.org/vie-de-la-sf...
15926
Guillaume Grenet @guillaume-grenet.bsky.social · 12/12/2024
www.bmj.com/content/387/...
bmj.com
Doubts over landmark heart drug trial: ticagrelor PLATO study
A top selling antiplatelet drug has never quite shaken off doubts about its advantage over cheaper rivals. With generic versions of ticagrelor about to launch, Peter Doshi takes a fresh look at the ev...
031